Alenzi FM. Myositis Specific Autoantibodies: A Clinical Perspective. Open Access Rheumatol. 2020;12:9-14. https://doi.org/10.2147/OARRR.S231195.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Nombel A, Fabien N, Coutant F. Dermatomyositis With Anti-MDA5 Antibodies: Bioclinical Features, Pathogenesis and Emerging Therapies. Front Immunol. 2021;12:773352. https://doi.org/10.3389/fimmu.2021.773352.

Article  CAS  PubMed  Google Scholar 

McHugh NJ, Tansley SL. Autoantibodies in myositis. Nat Rev Rheumatol. Apr 20 2018;14(5):290-302. https://doi.org/10.1038/nrrheum.2018.56.

Article  CAS  PubMed  Google Scholar 

Li L, Wang Q, Yang F, Wu C, Chen S, Wen X, Liu C, Li Y. Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis. Oncotarget. Apr 2017;8(16):26552–26564. https://doi.org/10.18632/oncotarget.15716.

Qudsiya Z, Waseem M. Dermatomyositis. StatPearls. 2023.

Cao H, Pan M, Kang Y, Xia Q, Li X, Zhao X, et al. Clinical manifestations of dermatomyositis and clinically amyopathic dermatomyositis patients with positive expression of anti-melanoma differentiation-associated gene 5 antibody. Arthritis Care Res (Hoboken). 2012;64(10):1602-10. https://doi.org/10.1002/acr.21728.

Article  PubMed  Google Scholar 

Concha JSS, Tarazi M, Kushner CJ, Gaffney RG, Werth VP. The diagnosis and classification of amyopathic dermatomyositis: a historical review and assessment of existing criteria. Br J Dermatol. 2019;180(5):1001-1008. https://doi.org/10.1111/bjd.17536.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moghadam-Kia S, Oddis CV, Sato S, Kuwana M, Aggarwal R. Anti-Melanoma Differentiation-Associated Gene 5 Is Associated With Rapidly Progressive Lung Disease and Poor Survival in US Patients With Amyopathic and Myopathic Dermatomyositis. Arthritis Care Res (Hoboken). 2016;68(5):689-94. https://doi.org/10.1002/acr.22728.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hall JC, Casciola-Rosen L, Samedy LA, et al. Anti-melanoma differentiation-associated protein 5-associated dermatomyositis: expanding the clinical spectrum. Arthritis Care Res (Hoboken). 2013;65(8):1307-15. https://doi.org/10.1002/acr.21992.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mihailescu ML, Edens C, Hoffman MD. Anti-MDA5 Antibody-Positive Interstitial Pneumonia with Autoimmune Features Presenting as Amyopathic Hypodermatitic Dermatomyositis: A Case Report. Case Rep Dermatol. 2021;13(1):222-229. https://doi.org/10.1159/000515245.

Article  PubMed  PubMed Central  Google Scholar 

Mehta P, Machado PM, Gupta L. Understanding and managing anti-MDA 5 dermatomyositis, including potential COVID-19 mimicry. Rheumatol Int. 2021;41(6):1021-36. https://doi.org/10.1007/s00296-021-04819-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sato Y, Otsuka K, Tamai K, Ono Y, Hamaguchi Y, Tomii K. An Atypical Clinical Course of Anti-MDA5 Antibody-positive Interstitial Lung Disease in a Patient with Three Deteriorations in 9 years. Intern Med. 2017;56(3):341-346. https://doi.org/10.2169/internalmedicine.56.6856.

Article  PubMed  PubMed Central  Google Scholar 

Vahora I, Lingireddy A, Nadella S, Trivedi B, Dihowm F. A Case Report on Rare Presentation of Sporadic Disease: Dermatomyositis Sine Dermatitis-Diagnosis and Management. J Investig Med High Impact Case Rep. 2022;10:23247096221121403. https://doi.org/10.1177/23247096221121403.

Article  PubMed  PubMed Central  Google Scholar 

Chudzinski AP, Thompson EV, Ayscue JM. Acute colonic pseudoobstruction. Clin Colon Rectal Surg. 2015;28(2):112-7. https://doi.org/10.1055/s-0035-1549100.

Article  PubMed  PubMed Central  Google Scholar 

McFarlane IM, Bhamra MS, Kreps A, Iqbal S, Al-Ani F, Saladini-Aponte C, et al. Gastrointestinal Manifestations of Systemic Sclerosis. Rheumatology (Sunnyvale). 2018;8(1). https://doi.org/10.4172/2161-1149.1000235.

Miyamae T, Ishiguro N, Yonezawa M, Tokushige K, Yamanaka H. Pneumatosis Intestinalis Associated with Juvenile Dermatomyositis. Case Rep Rheumatol. 2016;2016:6497357. https://doi.org/10.1155/2016/6497357.

Article  PubMed  PubMed Central  Google Scholar 

Valenzuela A, Li S, Becker L, Fernandez-Becker N, Khanna D, Nguyen L, et al. Intestinal pseudo-obstruction in patients with systemic sclerosis: an analysis of the Nationwide Inpatient Sample. Rheumatology (Oxford). 2016;55(4):654-8. https://doi.org/10.1093/rheumatology/kev393

Article  PubMed  Google Scholar 

Yamada C, Sato S, Sasaki N, Kurabayashi T, Sasaki S, Koyama Y, et al. A Case of Dermatomyositis and Anti-EJ Autoantibody with Chronic Intestinal Pseudoobstruction Successfully Treated with Octreotide. Case Rep Rheumatol. 2016;2016:9510316. https://doi.org/10.1155/2016/9510316.

Article  PubMed  PubMed Central  Google Scholar 

Airio A, Kautiainen H, Hakala M. Prognosis and mortality of polymyositis and dermatomyositis patients. Clin Rheumatol. 2006;25(2):234-9. https://doi.org/10.1007/s10067-005-1164-z.

Article  CAS  PubMed  Google Scholar 

He S, Zhou Y, Fan C, Ma J, Chen Y, Wu W, et al. Differences in sex- and Age-Associated Mortality in Patients with anti-MDA5 Positive Dermatomyositis. Mod Rheumatol. 2022. https://doi.org/10.1093/mr/roac091.

Article  PubMed  Google Scholar 

Niu Q, Zhao LQ, Ma WL, et al. A New Predictive Model for the Prognosis of MDA5(+) DM-ILD. Front Med (Lausanne). 2022;9:908365. https://doi.org/10.3389/fmed.2022.908365.

Article  PubMed  PubMed Central  Google Scholar 

Bendewald MJ, Wetter DA, Li X, Davis MD. Incidence of dermatomyositis and clinically amyopathic dermatomyositis: a population-based study in Olmsted County, Minnesota. Arch Dermatol. 2010;146(1):26-30. https://doi.org/10.1001/archdermatol.2009.328.

Article  PubMed  Google Scholar 

Xu W, Wu W, Zhang D, Chen Z, Tao X, Zhao J, et al. A novel CT scoring method predicts the prognosis of interstitial lung disease associated with anti-MDA5 positive dermatomyositis. Sci Rep. 2021;11(1):17070. https://doi.org/10.1038/s41598-021-96292-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sato S, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Tamura M, et al. Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology (Oxford). 2018;57(7):1212-21. https://doi.org/10.1093/rheumatology/key060.

Article  CAS  PubMed  Google Scholar 

Ouyang ZM, Lin JZ, Tang AJ, Yang ZH, Yang LJ, Wei XN, et al. A Matrix Prediction Model for the 6-Month Mortality Risk in Patients With Anti-Melanoma Differentiation-Associated Protein-5-Positive Dermatomyositis. Front Med (Lausanne). 2022;9:860798. https://doi.org/10.3389/fmed.2022.860798.

Article  PubMed  PubMed Central  Google Scholar